GH Filing
4Filing Date: Aug 5, 2026

Guardant Health, Inc. (GH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001336504-26-000008open_in_new
Total Value$2.80M
Trades6
Insiders1

Transaction Details

CLARK IAN T
Director·Indirect · By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Exercise · Acquire
Common Stock
Shares+6.83K
Price$50.57
Total Value$345.5K
Shares Owned After17.16K
Transaction DateAug 4, 2026
CLARK IAN T
Director·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-2.25K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateAug 4, 2026
ExpiresJun 18, 2029
Footnotes ▸

The stock option vested in full on June 12, 2020.

CLARK IAN T
Director·Indirect · By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Sell · Dispose
Common Stock
Shares-5.09K
Price$158.80
Total Value$808.6K
Shares Owned After2.98K
Transaction DateAug 4, 2026
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $158.51 to $159.14. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

CLARK IAN T
Director·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-6.83K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateAug 4, 2026
ExpiresJun 18, 2035
Footnotes ▸

The stock option vested in full on June 17, 2026.

CLARK IAN T
Director·Indirect · By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Exercise · Acquire
Common Stock
Shares+2.25K
Price$91.11
Total Value$205.5K
Shares Owned After10.32K
Transaction DateAug 4, 2026
CLARK IAN T
Director·Indirect · By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Sell · Dispose
Common Stock
Shares-9.09K
Price$158.98
Total Value$1.44M
Shares Owned After8.07K
Transaction DateAug 4, 2026
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $158.510 to $159.435. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Post-Transaction Holdings

CLARK IAN T
SecuritySharesChange
Common Stock17.16K-5.09K (-22.89%)
Stock Option (Right to Buy)0-9.09K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-04 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: CLARK IAN T CIK: 0001336504 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-04 | Code: M (Exercise of derivative) Shares: +2,255 | Price: $91.11 Total Value: $205,453.05 Shares Owned After: 10,322 | Ownership: I (Indirect) | Nature: By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account [Transaction #2] Security: Common Stock Date: 2026-08-04 | Code: M (Exercise of derivative) Shares: +6,833 | Price: $50.57 Total Value: $345,544.81 Shares Owned After: 17,155 | Ownership: I (Indirect) | Nature: By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account [Transaction #3] Security: Common Stock Date: 2026-08-04 | Code: S (Open market sale) Shares: -9,088 | Price: $158.98 Total Value: $1,444,824.78 Shares Owned After: 8,067 | Ownership: I (Indirect) | Nature: By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account Footnotes: [F1] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $158.510 to $159.435. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #4] Security: Common Stock Date: 2026-08-04 | Code: S (Open market sale) Shares: -5,092 | Price: $158.80 Total Value: $808,625.89 Shares Owned After: 2,975 | Ownership: I (Indirect) | Nature: By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account Footnotes: [F2] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $158.51 to $159.14. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-08-04 | Code: M (Exercise of derivative) Shares: -2,255 | Price: $0.00 Exercisable: N/A | Expires: 2029-06-18 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F3] The stock option vested in full on June 12, 2020. [Transaction #2] Security: Stock Option (Right to Buy) Date: 2026-08-04 | Code: M (Exercise of derivative) Shares: -6,833 | Price: $0.00 Exercisable: N/A | Expires: 2035-06-18 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F4] The stock option vested in full on June 17, 2026. --- Footnotes (Complete Index) --- F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $158.510 to $159.435. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $158.51 to $159.14. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F3: The stock option vested in full on June 12, 2020. F4: The stock option vested in full on June 17, 2026. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for Ian T. Clark (2026-08-05)

keid analysis is for reference only and does not constitute investment advice.